The post ATOM Technical Analysis Mar 23 appeared on BitcoinEthereumNews.com. ATOM is hovering at the 1.78 dollar level, stuck to the critical support zone at 1.The post ATOM Technical Analysis Mar 23 appeared on BitcoinEthereumNews.com. ATOM is hovering at the 1.78 dollar level, stuck to the critical support zone at 1.

ATOM Technical Analysis Mar 23

2026/03/23 12:17
4 min di lettura
Per feedback o dubbi su questo contenuto, contattateci all'indirizzo crypto.news@mexc.com.

ATOM is hovering at the 1.78 dollar level, stuck to the critical support zone at 1.7750, under downward trend pressure. Strong selling pressure is expected at nearby resistances, while BTC correlation carries additional risk for altcoins.

Current Price Position and Critical Levels

ATOM’s current price is positioned around 1.78 dollars, while the overall structure maintains its downward trend. Although the 24-hour change is limited to -0.78%, the price continues to stay below EMA20 (1.86 dollars) and RSI at 40.57 level gives a neutral-bearish signal. The range over the last 24 hours is squeezed between 1.75-1.81 dollars, with volume at low levels of 20.71 million dollars. In multi-timeframe (MTF) analysis, a total of 12 strong levels were identified across 1D, 3D, and 1W charts: 2 supports/3 resistances on 1D, 2S/1R on 3D, 3S/2R confluences on 1W. The price is below the short-term bearish Supertrend and is testing the 1.7750 support zone for a potential liquidity sweep. This position creates a liquidity pool that large players could target with their order blocks.

Support Levels: Buyer Pools

Primary Support

The strongest support level is 1.7750 dollars (score: 73/100), just below the current price and overlapping with the 24-hour low (1.75). This level stands out as a strong demand zone on the 1D timeframe; it has been tested 3 times in the past and rejected each time with volume increase. It has confluence with the order block on the 1W chart and aligns with the Fibonacci 0.618 retracement level. EMA50 (around 1.77) provides dynamic support here. A break of this zone means buyers capitulate and could trigger a sharp drop – invalidation level is a close below 1.7750.

Secondary Support and Stop Levels

Secondary support at 1.6540 dollars (score: 66/100) is a clear supply/demand imbalance point on the 3D timeframe. This level has historical test confluence with the November 2025 swing low; during that period, buyers entered with high volume. It functions as a breaker block on 1W and serves as the first stop on the path to the downside target of 1.2222 (score 22). Stop-loss recommended below 1.6540, as a break here accelerates bearish momentum and triggers a liquidity grab. Deeper supports are limited around 1.50 with weekly lows.

Resistance Levels: Seller Pools

Near-Term Resistances

The first near-term resistance is 1.8045 dollars (score: 64/100), a supply zone overlapping with the 24-hour high. It is the upper boundary of the imbalance gap on the 1D chart with confluence from the EMA20 (1.86) approach. Rejected twice in the past, sellers’ dominance is clear with low volume. Short squeeze risk is low as price approaches here, as there is no RSI divergence.

Main Resistance and Targets

Main resistances at 1.8797 dollars (score: 63/100) and 2.2986 dollars (score: 63/100). 1.8797 is a strong resistance order block on the 3D timeframe; rejected with volume spike during the February 2026 rally. It overlaps with Supertrend resistance at 2.04. Upper target 2.2986 is defined by 1W equal highs with low upside R/R ratio (approximately 1:2 against downside). Breaking these levels requires a strong BTC pump and high volume; otherwise, fakeouts are expected.

Liquidity Map and Large Players

The liquidity map shows stop-loss clusters below 1.7750 – large players (smart money) could sweep this to collect downside liquidity. Above, there is a liquidity pool of equal lows in the 1.8045-1.81 range, targeting short position stops. From a 1W perspective, price is squeezed below the weekly open (1.82); institutional order flow is bearish, as BTC dominance increase absorbs altcoin liquidity. Likely scenario: test and rejection at 1.7750 followed by drop to 1.65, then look for buyer confluence for a bounce.

Bitcoin Correlation

BTC is at 68,184 dollar level with -1.82% drop in downtrend; main supports at 68,086 / 66,388 / 64,377. Resistances at 69,552 / 71,680 / 74,560. ATOM shows high correlation with BTC (0.85%) – rally in altcoins is difficult while BTC Supertrend is bearish. If BTC breaks below 68k, ATOM’s 1.65 test accelerates; a close above 69.5k could challenge 1.80 resistance. BTC dominance rise shifts ATOM liquidity to BTC – stay cautious.

Trading Plan and Level-Based Strategy

Level-based outlook: If it holds above 1.7750, short-term bounce to 1.8045; break below targets 1.6540. Upside scenario requires break of 1.8797, downside major target 1.2222. Detailed data available in ATOM Spot Analysis and ATOM Futures Analysis. R/R ratio favors downside (1:3), risk management critical: 1-2% risk per trade. This analysis is not investment advice, market is volatile.

This analysis uses Chief Analyst Devrim Cacal’s market views and methodology.

Senior Technical Analyst: James Mitchell

6 years of crypto market analysis

This analysis is not investment advice. Do your own research.

Source: https://en.coinotag.com/analysis/atom-technical-analysis-march-23-2026-support-and-resistance-levels

Opportunità di mercato
Logo Ucan fix life in1day
Valore Ucan fix life in1day (1)
$0,0003502
$0,0003502$0,0003502
-5,47%
USD
Grafico dei prezzi in tempo reale di Ucan fix life in1day (1)
Disclaimer: gli articoli ripubblicati su questo sito provengono da piattaforme pubbliche e sono forniti esclusivamente a scopo informativo. Non riflettono necessariamente le opinioni di MEXC. Tutti i diritti rimangono agli autori originali. Se ritieni che un contenuto violi i diritti di terze parti, contatta crypto.news@mexc.com per la rimozione. MEXC non fornisce alcuna garanzia in merito all'accuratezza, completezza o tempestività del contenuto e non è responsabile per eventuali azioni intraprese sulla base delle informazioni fornite. Il contenuto non costituisce consulenza finanziaria, legale o professionale di altro tipo, né deve essere considerato una raccomandazione o un'approvazione da parte di MEXC.

Potrebbe anche piacerti

Supported by hike speculation and PMIs – Danske Bank

Supported by hike speculation and PMIs – Danske Bank

The post Supported by hike speculation and PMIs – Danske Bank appeared on BitcoinEthereumNews.com. Danske Research Team points out that the Euro was the second-
Condividi
BitcoinEthereumNews2026/03/23 15:59
The geopolitics of anti-corruption as global advisory firms face debarment in the Horn of Africa

The geopolitics of anti-corruption as global advisory firms face debarment in the Horn of Africa

The World Bank’s debarment of PwC and EY for fraud in Ethiopia and Somalia has lifted the veil on the fragility of the Western development model, creating a strategic
Condividi
Theexchange2026/03/23 16:33
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Condividi
BitcoinEthereumNews2025/09/18 03:11